Cours Shanrong Biotechnology Corp. Other OTC
Actions
SRBT
US81946R1077
Sociétés holdings
CA 2008 | 692 k 612 k | CA 2009 | 1,32 M 1,17 M | Capitalisation | 11,62 M 10,27 M |
---|---|---|---|---|---|
Résultat net 2008 | -2 M -1,77 M | Résultat net 2009 | -5 M -4,42 M | VE / CA 2008 | 45,1 x |
Dette nette 2008 | 2,53 M 2,24 M | Dette nette 2009 | 2,18 M 1,93 M | VE / CA 2009 | 10,4 x |
PER 2008 |
-10,5
x | PER 2009 |
-2,03
x | Employés | - |
Rendement 2008 * |
-
| Rendement 2009 |
-
| Flottant | 38,95% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 31/08/21 |
Qingping Zheng
BRD | Director/Board Member | - | - |
Guenter Volgger
PRN | Corporate Officer/Principal | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Frank Igwealor
CEO | Chief Executive Officer | 53 | 31/08/21 |
Qingping Zheng
BRD | Director/Board Member | - | - |
Varia. 1 janv. | Capi. | |
---|---|---|
+108,23% | 7,01 Md | |
+2,71% | 987 M | |
+51,02% | 976 M | |
+2,39% | 669 M | |
-.--% | 600 M | |
-2,15% | 593 M | |
+10,28% | 536 M | |
-.--% | 500 M | |
+4,83% | 470 M |